IPOGrid
0002071288
IPO filing research

Lumexa Imaging Holdings, Inc.

Services-Medical Laboratories · LMRI

ipo trading trading Nasdaq 424B4

Lumexa Imaging Holdings, Inc. IPO research page with SEC filing history, offering status, deal terms, structured filing extracts, company news, and comparable IPO context. Latest filing: 424B4 on 2025-12-12. Current deal snapshot: exchange Nasdaq.

Filing Timeline

SEC EDGAR
424B4 priced
Final prospectus
Final prospectus filed after pricing with final deal terms.
Follows CERT and confirms the priced prospectus.
Price $18.50 · 25,000,000 shares · Gross proceeds $434,750,000
Common Stock · Exchange Nasdaq · Ticker LMRI · Over-allotment 3,750,000 · Underwriters Barclays, J.P. Morgan, Jefferies
2025-12-12 · 0001193125-25-316455
CERT inactive
CERT
Pre-IPO filing captured from the SEC submission timeline.
Follows 8-A12B in the pre-IPO sequence.
2025-12-11 · 0001354457-25-001252
8-A12B effective
Exchange Act registration
Registration filed to list the securities under the Exchange Act ahead of trading.
Follows EFFECT and registers the class of securities for exchange listing.
2025-12-11 · 0001193125-25-314999
EFFECT effective
SEC effectiveness notice
SEC declared the registration statement effective, allowing the offering to proceed.
Follows S-1/A and marks the registration effective.
2025-12-10 · 9999999995-25-003634
S-1/A amended
Amended registration statement
Updated registration statement filed after SEC comments or deal changes.
Updates the prior S-1 filing.
Price $18.50 · Range $17.00 to $20.00 · 25,000,000 shares · Gross proceeds $462,500,000
Common · Exchange Nasdaq · Ticker LMRI · Over-allotment 3,750,000 · Use of proceeds general corporate purposes · Underwriters Barclays, J.P. Morgan, Jefferies
2025-12-02 · 0001193125-25-304460
S-1 filed
Initial registration statement
Initial public filing submitted to start the SEC review process.
Follows DRS/A in the pre-IPO sequence.
Common Stock · Exchange Nasdaq Global Market · Ticker LMRI · Use of proceeds Proceeds will be used for general corporate purposes, including debt repayment and working capital. · Underwriters Barclays, J.P. Morgan, Jefferies
2025-11-17 · 0001193125-25-284663
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2025-10-10 · 0001193125-25-237018
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS/A filing.
2025-09-12 · 0000950123-25-008708
DRS/A amended
Amended draft registration statement
Updated draft registration filed before the public launch.
Updates the prior DRS filing.
2025-08-07 · 0000950123-25-007241
DRS filed
Draft registration statement
Draft registration filed confidentially before the public launch.
First tracked pre-IPO filing for this issuer.
2025-06-12 · 0000950123-25-006005
Comparable Deals

3 comparable deals

Healthcare & Biotech$300M-1BBarclaysLast 18 months
Only 0 strict matches; expanded to 3 using nearest neighbors.
+40.0%
Median day-1
67%
Above issue
+69.7%
Median week-1
-21.2%
Downside (p10)
BillionToOne, Inc. BLLN
2025-11-06 $273M Day 1: +81.6% Wk 1: +69.7%
same SICnearby deal sizerecent IPO
Park Dental Partners, Inc. PARK
2025-12-03 $20M Day 1: -21.2% Wk 1: +21.3%
same SIC grouprecent IPO
Charming Medical Ltd MCTA
2025-10-21 $8M Day 1: +40.0% Wk 1: +93.4%
same SIC grouprecent IPO

Recent News

No recent news stored for this issuer.